Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

19.26B

Market cap19.26B

Price-Earnings ratio

23.12

Price-Earnings ratio23.12

Dividend yield

—

Dividend yield—

Average volume

1.67M

Average volume1.67M

High today

$126.67

High today$126.67

Low today

$122.27

Low today$122.27

Open price

$123.11

Open price$123.11

Volume

966.84K

Volume966.84K

52 Week high

$155.53

52 Week high$155.53

52 Week low

$68.70

52 Week low$68.70

Stock Snapshot

As of today, Illumina(ILMN) shares are valued at $125.98. The company's market cap stands at 19.26B, with a P/E ratio of 23.12.

On 2026-03-25, Illumina(ILMN) stock traded between a low of $122.27 and a high of $126.67. Shares are currently priced at $125.98, which is +3.0% above the low and -0.5% below the high.

The Illumina(ILMN)'s current trading volume is 966.84K, compared to an average daily volume of 1.67M.

During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $155.53 at its peak.

ILMN News

Simply Wall St 23h

Assessing Illumina Valuation After New Labcorp And Preventive Genomics Alliances

Advertisement Why Illumina’s new alliances matter for stock watchers Illumina (ILMN) has just expanded its collaboration with Labcorp and entered a new consor...

TipRanks 2d

Illumina: Neutral Stance Amid Emerging Roche Competition and Incremental NovaSeq X Enhancements

Analyst Kyle Mikson CFA from Canaccord Genuity maintained a Hold rating on Illumina and keeping the price target at $150.00. Kyle Mikson CFA has given his Hold...

Nasdaq 7d

Illumina Expands Collaboration With Labcorp To Advance Precision Oncology

(RTTNews) - Illumina, Inc. (ILMN), Wednesday announced an expanded collaboration with Labcorp to advance precision oncology through innovative applications of n...

Analyst ratings

43%

of 23 ratings

Buy

43.5%

Hold

43.5%

Sell

13%

More ILMN News

TipRanks 7d

Labcorp, Illumina expand collaboration to broaden access to oncology testing

Illumina (ILMN) and Labcorp (LH) announced an expanded collaboration to advance precision oncology through applications of next-generation sequencing solutions...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.